Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHIPP-PrEP: Cabotegravir-Hormone Interrogation of Pharmacokinetics/Pharmacodynamics (PK/PD) for HIV Prevention

NCT07672717 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT07672717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07672717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHIPP-PrEP: Cabotegravir-Hormone Interrogation of Pharmacokinetics/Pharmacodynamics (PK/PD) for HIV Prevention
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Recruiting
Start date
July 7, 2026
Completion date
December 31, 2031
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, injectable, prophylaxis